standard]
MNSGAGSGLRHSVIGDGSGSGNRNMNSIGSSGSQGIYNAAPDHEVDYVEK
CPRGQYVRYNEVLGKGAFKTVYKAFDQVDGIEVAWNRVKIDEVLQSPQDL
EKLYSEVHLVKQLKHENIIKFYDSWIDEKKKTINMITELFTSGSLRQYRK
KHKTVDMKAIKNWARQILRGLDYLHSQIPPVIHRDLKCDNILVNGNQGEV
KIGDLGLATILQRPTAKSVIGTPEFMAPELYEEEYNELVDIYSFGMCLLE
MVTLDYPYSECKNPAQIFRKVTKGLKPAALGKVSSPEVKEFIEKCLAPAS
QRLSAKELLRDPFLQSEHSKLPVVDLLQIPNEAPRFLSTFICGPHSMDID
HEYNQSQCPDSNSGSSCSSVLEIQRVHLNNEFRLKGKKNDDSSISLTLRI
ADQGGRVRNIHFLFYLDSDTALAVAAEMVEQLDLAEHDVAFIADFIDFLI
MRILPNWKPSSCCLSSAERRASGLTLMPDQWETPVAGSPAELVVKQDDAC
EFHMDPRIFVPAVNGHNLYGNSSIASPHVSFALSPCFTINTGNKLSHGSA
TSEVLGEDSLRRSVMSKGSSAEASERDFRDLYCAECRLRAVESGNLEYPA
HRDQLAENSDLVFSDQDTFSKGSPCSTLTLQRRDPEAELKLELDAIEAQY
QQWFQELLRMKQDAMEETKKRWMAKDKVVVH
|
IPR000719; Protein kinase, catalytic domain IPR002290; Serine/threonine-protein kinase domain IPR008271; Serine/threonine-protein kinase, active site IPR017442; Serine/threonine-protein kinase-like do |